NCT06576921

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2024-11-15Est. Completion: 2026-08-10

Enrollment target: 116 participants

Locations

The fourth hospital of Hebei Medical University, Shijiazhuang, Heibei Province, China
Department of Digestive surgery, Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi' an, China, Xi'an, Shaanxi, China
Department of General Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China
Department of General Surgery, The 986th Military Hospital, Air Force Medical University, Xi'an, Shaanxi, China
Tianjin Medical University Cancer Institute & Hospital, Tianjin, China

Other microbiome trials you might be interested in

Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDSRecruiting

ARDS (Moderate or Severe)

To verify whether the transpulmonary pressure-guided mechanical ventilation strategy can reduce right ventricular involv…

Beijing, ChinaEst. completion Mar 31, 2028

View Trial →

Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric AdenocarcinomaPhase 2Recruiting

Esophageal CancerGastric (Stomach) CancerGastric AdenocarcinomaGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaEsophageal CarcinomaGastric (Cardia, Body) Cancer

Purpose of the Study: This clinical study investigates whether a shorter or longer duration of systemic therapy before …

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.